Fastest Growing Revenue Stocks
Companies with the highest year-over-year revenue growth rates — the raw engine of long-term wealth creation when combined with improving margins and strong unit economics.
| Ticker | Company | Price | Rev. Growth | Net Margin | Mkt Cap | P/E |
|---|---|---|---|---|---|---|
| UROY | Uranium Royalty Corp | $3.37 -3.16% | 416400% | 8% | $494M | 112.3x |
| ASTS | AST SpaceMobile | $105.86 +10.01% | 1952.2% | 0% | $41.09B | — |
| RNA | Avidity Biosciences | $13.09 +0.38% | 1148.3% | -160% | $223.9M | — |
| MNTS | Momentus Space | $7.38 -2.25% | 898.4% | 0% | $73.7M | — |
| RCAT | Red Cat Holdings | $9.41 +4.21% | 849.1% | -138.4% | $1.43B | — |
| ZEAL.CO | Zealand Pharma | $318.00 +0.98% | 325% | 69.2% | $22.41B | 3.6x |
| BEAM | Beam Therapeutics | $28.64 +3.51% | 324.9% | -40.2% | $2.95B | — |
| WKHS | Workhorse Group | $3.19 +0.63% | 278.1% | -292.3% | $34.7M | — |
| INSM | Insmed | $106.24 -3% | 229.6% | -144.4% | $23.03B | — |
| TIP.MI | Tamburi Investment Partners | $8.64 +0.47% | 227.4% | 1692.7% | $1.41B | 25.4x |
| LUNR | Intuitive Machines | $38.26 +11.74% | 198.7% | -32.7% | $6.14B | — |
| USAS | Americas Gold and Silver | $5.79 +1.49% | 187.9% | -35.6% | $1.89B | — |
| RKT | Rocket Companies | $13.80 -0.5% | 167.1% | 2.7% | $39.05B | — |
| AVAV | AeroVironment | $174.23 +6.83% | 143.4% | -13.9% | $8.82B | — |
| AGIO | Agios Pharmaceuticals | $28.14 -2.26% | 137.7% | 0% | $1.67B | — |
| ARIS | Aris Water Solutions | $17.25 -0.29% | 136.5% | 15.2% | $3.56B | 19.8x |
| MDGL | Madrigal Pharmaceuticals | $517.26 +0.71% | 126.8% | -27.3% | $11.93B | — |
| SMCI | Super Micro Computer | $35.58 +6.34% | 122.7% | 3.7% | $21.4B | 18.7x |
| MP | MP Materials | $64.44 +4.37% | 118.6% | -20.5% | $11.47B | — |
| NIO | NIO | $5.21 -7.05% | 112.2% | -9.1% | $13.04B | — |
| PTGX | Protagonist Therapeutics | $99.19 -2.76% | 99% | -154.9% | $6.38B | — |
| STRL | Sterling Infrastructure | $732.94 -0.11% | 91.6% | 12% | $22.49B | 65.3x |
| EKT.DE | Energiekontor | $49.70 +1.02% | 89.7% | 24.4% | $691.4M | 20x |
| VXRT | Vaxart | $0.64 -7.17% | 87.9% | 14.5% | $155M | 4x |
| NVDA | NVIDIA | $215.30 -1.92% | 85.2% | 63% | $5.21T | 33x |
| PLTR | Palantir | $136.88 -0.39% | 84.7% | 43.7% | $328.14B | 153.8x |
| RYTM | Rhythm Pharmaceuticals | $87.84 -2.61% | 83.8% | -93.3% | $6.02B | — |
| HYPR | Hyperfine | $1.49 -0.67% | 82.6% | -226.9% | $147.9M | — |
| AGI | Alamos Gold | $38.34 -2.32% | 79.2% | 51.2% | $16.1B | 15.3x |
| FSM | Fortuna Silver Mines | $9.34 -0.85% | 75.6% | 31.1% | $2.83B | 8.7x |
| TGTX | TG Therapeutics | $38.87 -0.94% | 69.6% | 66% | $5.95B | 13.6x |
| RKLB | Rocket Lab USA | $135.76 +8.22% | 63.5% | -26.9% | $78.57B | — |
| FCEL | FuelCell Energy | $25.01 -5.19% | 60.7% | -107.5% | $1.32B | — |
| ARQT | Arcutis Biotherapeutics | $20.86 -0.71% | 60.1% | -0.6% | $2.61B | — |
| DBRG | DigitalBridge Group | $15.70 -0.03% | 58.9% | 122.6% | $3.06B | 29.6x |
| RDW | Redwire Corporation | $17.47 +13.81% | 57.9% | -80.9% | $3.48B | — |
| AXSM | Axsome Therapeutics | $235.97 +1% | 57.4% | -26.6% | $12.14B | — |
| STEP | StepStone Group | $53.74 -1.83% | 55.8% | -26.9% | $6.74B | — |
| TVTX | Travere Therapeutics | $44.43 -0.69% | 55.6% | -4% | $4.13B | — |
| LLY | Eli Lilly | $1,066.82 +2.42% | 55.5% | 35% | $951.33B | 37.9x |
| FUTU | Futu Holdings | $89.76 -27.53% | 53.1% | 53.8% | $12.58B | 8.8x |
| KLIC | Kulicke and Soffa | $104.40 +3.27% | 49.8% | 7.2% | $5.46B | 101.4x |
| SLR.MC | Solaria Energia | $24.15 +2.5% | 48.6% | 48% | $3.2B | 22x |
| DAVE | Dave Inc | $228.46 -5.16% | 46.7% | 37.2% | $2.9B | 14.7x |
| SE | Sea Limited | $87.26 -1.91% | 46.6% | 6.4% | $53.45B | 34.4x |
| COF | Capital One | $187.80 +0.61% | 46.3% | 8.9% | $116.87B | 57.8x |
| REMEDY.HE | Remedy Entertainment | $14.08 -0.85% | 46.3% | -21.9% | $191.4M | — |
| EVGO | EVgo | $1.88 +0% | 45.5% | -11.2% | $590.1M | — |
| IOVA | Iovance Biotherapeutics | $4.11 +11.08% | 44.8% | -123.9% | $1.84B | — |
| UPST | Upstart Holdings | $28.56 -1.01% | 44.6% | 4.2% | $2.73B | 69.7x |
| VIAV | Viavi Solutions | $49.51 +1.08% | 42.8% | -4% | $12.13B | — |
| SOFI | SoFi Technologies | $15.62 -0.19% | 42.5% | 14.8% | $20.04B | 34.7x |
| HALO | Halozyme Therapeutics | $68.32 -0.29% | 42.2% | 23.1% | $8.1B | 24x |
| FLYW | Flywire Corporation | $16.12 -0.25% | 41% | 4.5% | $1.99B | 67.2x |
| RBLX | Roblox | $48.19 +4.44% | 39.3% | -20.7% | $34.5B | — |
| NTRA | Natera | $203.19 -0.25% | 38.8% | -9.1% | $29.1B | — |
| GRND | Grindr | $12.96 +1.01% | 38.3% | 19.9% | $2.3B | 28.2x |
| AMD | AMD | $467.41 +3.96% | 37.8% | 13.4% | $762.16B | 155.3x |
| MOL.MI | Mutuionline | $31.40 +1.78% | 37.6% | 5.3% | $1.18B | 30.5x |
| COCO | Vita Coco Company | $76.04 -3.54% | 37.3% | 12.6% | $4.34B | 55.1x |
| EMBRAC-B.ST | Embracer Group | $70.96 +0.82% | 36.8% | 5.7% | $15.84B | — |
| TSM | TSMC | $404.22 -0.72% | 35.1% | 46.5% | $2.1T | 34.9x |
| ELF | elf Beauty | $52.93 -0.36% | 35.1% | -0.2% | $3.15B | 120.3x |
| SIP.BR | Sipef | $95.20 +1.28% | 34.4% | 22% | $994.9M | 9.2x |
| SHOP | Shopify | $103.00 -1.77% | 34.3% | 10.8% | $133.66B | 101x |
| NET | Cloudflare | $216.32 +1.73% | 33.5% | -3.7% | $76.46B | — |
| ESE | ESCO Technologies | $295.41 +0.73% | 33.5% | 24.7% | $7.65B | 58.3x |
| ALHC | Alignment Healthcare | $16.35 -0.12% | 33.3% | 0.5% | $3.38B | 163.5x |
| META | Meta Platforms | $610.32 +0.48% | 33.1% | 32.8% | $1.55T | 22.2x |
| AFRM | Affirm Holdings | $65.22 -2.92% | 32.6% | 9.6% | $21.84B | 59.3x |
| DDOG | Datadog | $222.32 +1.96% | 32.2% | 3.7% | $79.14B | 570.1x |
| FOUR | Shift4 Payments | $43.23 -0.69% | 32.2% | 2.6% | $4.29B | 49.7x |
| FORM | FormFactor | $128.99 +0.77% | 32% | 8.1% | $10.06B | 148.3x |
| BROS | Dutch Bros | $52.10 -2.54% | 30.8% | 4.6% | $9.1B | 81.4x |
| FAE.MC | Faes Farma | $4.63 +0.33% | 30.8% | 12.2% | $1.44B | 18.5x |
| SNOW | Snowflake | $172.27 +4.07% | 30.1% | -28.4% | $59.71B | — |
Analysis and Context
This screener identifies 76 growth stocks meeting our growth criteria — updated daily. The average revenue growth rate of listed companies is 5617.6% annually. Growth companies are heavily concentrated in Healthcare (20 companies). High revenue growth alone doesn't make a great investment — the path to profitability and quality of growth (organic vs. acquisition-driven) are equally critical. The median net margin of companies in this list is 11.1%. Analysts see an average of 39.6% upside in these growth names. Growth stocks are particularly sensitive to interest rate changes — rising rates increase the discount rate and reduce the present value of future earnings. Use this list as a starting point for deeper research into unit economics, customer retention, and total addressable market.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →